PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1. A total of 37 filers reported holding PDL BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,000 | -99.9% | 1,000 | -99.9% | 0.00% | – |
| Q3 2016 | $673,000 | -71.2% | 699,000 | -71.9% | 0.00% | -100.0% |
| Q2 2016 | $2,337,000 | -59.5% | 2,486,000 | -61.7% | 0.00% | -50.0% |
| Q1 2016 | $5,772,000 | -48.2% | 6,485,000 | -53.7% | 0.00% | -50.0% |
| Q4 2015 | $11,144,000 | -19.5% | 13,998,000 | -10.9% | 0.00% | -33.3% |
| Q3 2015 | $13,840,000 | +4.4% | 15,709,000 | +12.5% | 0.01% | +20.0% |
| Q2 2015 | $13,263,000 | -58.5% | 13,962,000 | -58.2% | 0.01% | -16.7% |
| Q1 2015 | $31,954,000 | +57.2% | 33,390,000 | +57.1% | 0.01% | -25.0% |
| Q4 2014 | $20,330,000 | +17.5% | 21,259,000 | +19.8% | 0.01% | +14.3% |
| Q3 2014 | $17,302,000 | +2951.5% | 17,751,000 | +3478.8% | 0.01% | – |
| Q2 2014 | $567,000 | -41.6% | 496,000 | -45.9% | 0.00% | – |
| Q1 2014 | $971,000 | – | 916,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|